Not a good buy right now: price is in an uptrend but sitting just below key resistance (~31.20) with momentum starting to fade.
Fundamentals in the latest reported quarter (2025/Q3) deteriorated sharply (profit/margins down materially), which weakens the risk/reward for an impatient entry.
Options positioning (OI put/call > 1) leans defensive/bearish while option volume is effectively absent, so sentiment confirmation is weak.
Trend/structure: Bullish moving average stack (SMA_5 > SMA_20 > SMA_200) supports an ongoing uptrend.
Momentum: MACD histogram is positive (0.182) but positively contracting, implying upside momentum is weakening rather than accelerating.
RSI: RSI_6 = 66.98 (neutral-to-warm), approaching overbought; suggests less attractive entry now versus on a pullback.
Key levels: Pivot 29.83 is the near-term line to hold; resistance R1 ~31.20 then R2 ~32.04. With post-market ~30.85, upside is relatively capped until a clean break above ~31.20.
Pattern-based odds: Similar-pattern stats imply a mild edge short-term (next week +4.66%), but next-month expectation is near flat (+0.35%), aligning with “uptrend but not a strong fresh entry.”
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest: Calls 72 vs Puts 91 (PCR 1.26) = slightly bearish/hedged positioning.
Volume: 0 contracts traded today (put/call volume ratio 0.0) = options market is not providing real-time sentiment confirmation.
Volatility: 30d IV ~73.54% vs historical vol ~30.39% (IV elevated) and IV percentile ~72.91 = pricing in elevated uncertainty; not a “calm” sentiment backdrop.
Technical Summary
Sell
4
Buy
9
Positive Catalysts
Clean bullish MA alignment suggests the primary trend is still up.
No notable negative news flow in the past week (no headline overhang indicated).
Hedge fund / insider trends are neutral (no detected distribution pressure from these cohorts).
Neutral/Negative Catalysts
while MACD momentum is fading.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 138.286M, +0.60% YoY (modest growth).
Net income: 4.354M, -87.87% YoY (major contraction).
EPS: 0.40, -87.77% YoY.
Gross margin: 21.96%, down ~4.73% YoY.
Takeaway: top line is stable, but profitability and margins weakened sharply—this reduces confidence in paying up near resistance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, suggesting limited/unclear recent Street activity.
Wall Street-style pros: the chart trend is constructive and revenue is not collapsing.
Wall Street-style cons: sharp EPS/net income and margin deterioration in 2025/Q3 would likely pressure ratings/targets unless management shows a clear rebound path.
Politicians/congress: No recent congress trading data available (no observable influential-figure catalyst from the provided dataset).
Wall Street analysts forecast FSTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSTR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast FSTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSTR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
